Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension

Changqing Ma, Jeffrey S. Crippin, William C. Chapman, Kevin Korenblat, Neeta Vachharajani, Kristen L. Gunter, Elizabeth M. Brunt – 5 March 2013 – Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPH) are distinct pulmonary vascular complications of cirrhosis. Little is known about possible associated hepatic histopathological features.

Innate immune responses in hepatitis C virus‐exposed healthcare workers who do not develop acute infection

Jens Martin Werner, Theo Heller, Ann Marie Gordon, Arlene Sheets, Averell H. Sherker, Ellen Kessler, Kathleen S. Bean, M'Lou Stevens, James Schmitt, Barbara Rehermann – 5 March 2013 – Hepatitis C virus (HCV) infection typically results in chronic disease with HCV outpacing antiviral immune responses. Here we asked whether innate immune responses are induced in healthcare workers who are exposed to small amounts of HCV, but do not develop systemic infection and acute liver disease.

Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification

Diren Beyoğlu, Sandrine Imbeaud, Olivier Maurhofer, Paulette Bioulac‐Sage, Jessica Zucman‐Rossi, Jean‐François Dufour, Jeffrey R. Idle – 5 March 2013 – Hepatocellular carcinoma (HCC) is one of the commonest causes of death from cancer. A plethora of metabolomic investigations of HCC have yielded molecules in biofluids that are both up‐ and down‐regulated but no real consensus has emerged regarding exploitable biomarkers for early detection of HCC. We report here a different approach, a combined transcriptomics and metabolomics study of energy metabolism in HCC.

Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure

Annika Mutanen, Jouko Lohi, Päivi Heikkilä, Antti I. Koivusalo, Risto J. Rintala, Mikko P. Pakarinen – 4 March 2013 – The aim of this study was to evaluate the long‐term effects of pediatric intestinal failure (IF) on liver histology. Altogether, 38 IF patients (median age: 7.2 years; range, 0.2‐27) underwent liver biopsy, gastroscopy, abdominal ultrasound, and laboratory tests. Sixteen patients were on parenteral nutrition (PN) after 74 PN months (range, 2.5‐204). Twenty‐two had weaned off PN 8.8 years (range, 0.3‐27) earlier, after 35 PN months (range, 0.7‐250).

Cellular‐specific role of toll‐like receptor 4 in hepatic ischemia‐reperfusion injury in mice

Gary W. Nace, Hai Huang, John R. Klune, Raymond E. Eid, Brian R. Rosborough, Sebastian Korff, Shen Li, Richard A. Shapiro, Donna B. Stolz, Chhinder P. Sodhi, David J. Hackam, David A. Geller, Timothy R. Billiar, Allan Tsung – 4 March 2013 – Ischemia‐reperfusion (I/R) injury is a process whereby an initial hypoxic insult and subsequent return of blood flow leads to the propagation of innate immune responses and organ injury. The necessity of the pattern recognition receptor, Toll‐like receptor (TLR)4, for this innate immune response has been previously shown.

Overexpressed‐eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma

Yi‐Wei Wang, Kuen‐Tyng Lin, Shu‐Chuan Chen, De‐Leung Gu, Chian‐Feng Chen, Pang‐Hsien Tu, Yuh‐Shan Jou – 4 March 2013 – Eukaryotic translation initiation factor 3 subunit I (eIF3I) with transforming capability is often overexpressed in human hepatocellular carcinoma (HCC) but its oncogenic mechanisms remain unknown. We demonstrate that eIF3I is overexpressed in various cancers along with activated Akt1 phosphorylation and kinase activity in an eIF3I dose‐dependent manner.

Subscribe to